Gilead Sciences, Inc.GILDNASDAQ
Loading
Asset Growth Under PressureDecelerating
Percentile Rank64
3Y CAGR-5.2%
5Y CAGR-41.6%
Year-over-Year Change
Year-over-year total asset growth rate
3Y CAGR
-5.2%/yr
Quarterly compound
5Y CAGR
-41.6%/yr
Recent acceleration
Percentile
P64
Within normal range
vs 5Y Ago
0.1x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | 0.84% |
| Q3 2025 | 5.05% |
| Q2 2025 | -1.26% |
| Q1 2025 | -4.34% |
| Q4 2024 | 8.20% |
| Q3 2024 | 1.77% |
| Q2 2024 | -4.82% |
| Q1 2024 | -9.39% |
| Q4 2023 | -0.40% |
| Q3 2023 | 0.06% |
| Q2 2023 | 0.75% |
| Q1 2023 | -2.05% |
| Q4 2022 | 0.98% |
| Q3 2022 | -0.50% |
| Q2 2022 | -0.33% |
| Q1 2022 | -7.17% |
| Q4 2021 | 1.27% |
| Q3 2021 | -1.30% |
| Q2 2021 | 0.73% |
| Q1 2021 | -1.34% |
| Q4 2020 | 12.37% |
| Q3 2020 | 8.84% |
| Q2 2020 | -6.37% |
| Q1 2020 | -3.06% |
| Q4 2019 | 4.19% |
| Q3 2019 | -6.43% |
| Q2 2019 | 0.59% |
| Q1 2019 | -1.32% |
| Q4 2018 | -0.98% |
| Q3 2018 | -1.61% |
| Q2 2018 | -0.04% |
| Q1 2018 | -6.97% |
| Q4 2017 | 8.69% |
| Q3 2017 | 7.30% |
| Q2 2017 | 4.44% |
| Q1 2017 | 1.27% |
| Q4 2016 | 0.65% |
| Q3 2016 | 13.26% |
| Q2 2016 | 4.64% |
| Q1 2016 | -7.64% |